Find out more about KIMMTRAK▼ (tebentafusp).

For UK residents only. Adverse event reporting details can be found below.

To find information on KIMMTRAK^▼ (Tebentafusp) you can access the following external links to the Electronic Medicines Compendium (eMC)where Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL) are hosted.

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/. Adverse events should also be reported to Immunocore.

To find information on KIMMTRAK▼ (Tebentafusp) you can access the following external links to the Electronic Medicines Compendium (eMC)where Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL) are hosted.

Contact an IMMUNOCORE Representative

To find information on KIMMTRAK^▼ (Tebentafusp) you can access the following external links to the Electronic Medicines Compendium (eMC)where Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL) are hosted.